BioHealth News
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it is in the final stages for the launch of its 212-patient Confirmatory Registration Study for Multikine*…
Read More
Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA
GERMANTOWN, Md.--(BUSINESS WIRE)--Amarex today announced its work on behalf of Britecyte has resulted in a “safe to proceed” status by the United States Food…
Read More
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S.…
Read More
Georgetown Research and Innovation Showcase: Connecting Academia, Industry, and Investors
On April 1, 2025, Georgetown University’s Office of Technology Commercialization, in partnership with the Georgetown Entrepreneurship Initiative, will host the first-ever Georgetown Research and…
Read More
Governor Moore Names Harry Coker, Jr. as Maryland Department of Commerce Secretary
BALTIMORE, MD (January 24, 2025) – Governor Wes Moore today announced the appointment of Harry Coker, Jr. as secretary of the Maryland Department of Commerce. Coker…
Read More
TEDCO Invests in Novel Microdevices
Maryland-founded healthcare company continues to lead in medical diagnostic innovation COLUMBIA, Md., (February 18, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
BHI Board Member Juergen Klenk Discusses the Future of AI in Federal Health with Deloitte AI Institute
The Deloitte AI Institute has launched a new video series, You, Me, and Three: GenAI Questions, featuring industry leaders discussing the rapid transformation of…
Read More
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat Platform SARASOTA, Fla. and RICHMOND, Va.,…
Read More
Children’s National and Compremium partner on pediatric medtech innovation
WASHINGTON, DC / BERN, SWITZERLAND - Children’s National Hospital and Compremium AG entered into a strategic partnership to develop and commercialize cutting-edge medical technologies…
Read More
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing, offering accelerated and comprehensive…
Read More
Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
BALTIMORE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S.…
Read More
SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?
By Conor Gowder & Mark Skinner The Feb. 7, 2025, memo from the NIH Office of the Director (NOT-OD-25-068), now on hold because of…
Read More
TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort
The sixth cohort will undergo the first iteration of the program’s new structure COLUMBIA, Md., (February 13, 2025) — TEDCO, Maryland’s economic engine for…
Read More
Volition: Celebrating women in science: empowering the future
As we celebrate Women in Science Day and Women’s History Month, we are proud to spotlight the women of Volition. From driving groundbreaking innovation…
Read More
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T…
Read More